REVOLUNE
Live / Applied — New application — not yet assigned to an examiner (as of 12 Mar 2026)
What this means for you
Not registered yet, but its 12 Mar 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99698117
- Mark type
- Stylized text
- Filed
- 12 Mar 2026
- Attorney of record
- Ronald S. Kadden
Goods and services
- Class 001 — Chemicals: Reagents and reagent kits for scientific purposes; Biochemical reagents and reagent kits used for non-medical purposes; Diagnostic reagents and reagent kits for scientific or research use; all the aforesaid goods for multiplex immunofluorescence (miF) in the field of tissue multiplexing and in the 3D tissue field
- Class 005 — Pharmaceuticals: Clinical diagnostic reagents and reagent kits; Medical diagnostic reagents and reagent kits; Chemical reagents and reagent kits for medical purposes; Biological reagents and reagent kits for medical use; Diagnostic reagents and reagent kits for medical use; Immunoassay reagents and reagent kits for medical use; Diagnostic biomarker reagents and reagent kits for medical purposes; all the aforesaid goods for multiplex immunofluorescence (miF) in the field of tissue multiplexing and in the 3D tissue field
- Class 009 — Scientific and electric apparatus: Software for multiplex immunofluorescence (miF) in the field of tissue multiplexing and in the 3D tissue field; Software for image analysis and processing; Software for microscopy
- Class 042 — Scientific and technological services: Development, programming and implementation of software for multiplex immunofluorescence (miF) in the field of tissue multiplexing and in the 3D tissue field; Development, programming and implementation of software for image analysis and processing; Development, programming and implementation of software for microscopy; Software as a service [SaaS] for multiplex immunofluorescence (miF) in the field of tissue multiplexing and in the 3D tissue field; Software as a service [SaaS] for image analysis and processing; Software as a service [SaaS] for microscopy; Platform as a service [PaaS] for multiplex immunofluorescence (miF) in the field of tissue multiplexing and in the 3D tissue field; Platform as a service [PaaS] for image analysis and processing; Platform as a service [PaaS] for microscopy; Advisory services for multiplex immunofluorescence (miF) in the field of tissue multiplexing and in the 3D tissue field; Advisory services for image analysis and processing; Advisory services for microscopy; Scientific research services
Owner
- Carl Zeiss Microscopy GmbH, Jena, DE
Prosecution history
- 12 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 12 Mar 2026 — NEW APPLICATION ENTERED